Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Karolinska Institutet
- Technical University of Denmark
- University of Oslo
- ;
- RMIT University
- University of Nottingham
- SciLifeLab
- International PhD Programme (IPP) Mainz
- The University of Iowa
- University of Antwerp
- ; University of East Anglia
- ; University of Southampton
- Duke University
- ETH Zurich
- ; University of Nottingham
- Heidelberg University
- Radboud University Medical Center (Radboudumc)
- The Netherlands Cancer Institute
- University of Adelaide
- University of Basel
- University of Pittsburgh
- University of Utah
- ; Newcastle University
- ; University of Sussex
- AcademicTransfer
- Aix-Marseille Université
- Amsterdam UMC
- Curtin University
- Ghent University
- International Institute of Molecular and Cell Biology in Warsaw
- KU Leuven
- Leibniz
- Leibniz Institute for Plasma Science and Technology
- Monash University
- Stockholm University
- Technical University of Munich
- The Ohio State University
- Umeå University
- University Medical Centre Groningen (UMCG)
- Uppsala University
- ; University of Bradford
- ; University of Leeds
- ; University of Surrey
- Biobizkaia Health Research Institute
- Itä-Suomen yliopisto
- KTH Royal Institute of Technology
- KU Leuven (Coordinator)
- Leiden University
- NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU
- NTNU Norwegian University of Science and Technology
- Rutgers University
- The University of Chicago
- Trinity College Dublin
- University College Dublin
- University of Copenhagen
- University of Glasgow
- University of Houston
- University of Maryland, Baltimore
- University of Warsaw
- Utrecht University
- Vrije Universiteit Amsterdam (VU)
- Łukasiewicz Research Network – PORT Polish Center for Technology Development
- ; German Cancer Research Center (DKFZ)
- ; Leeds Beckett University
- ; Midlands Graduate School Doctoral Training Partnership
- ; Oxford Brookes University
- ; Swansea University
- ; The Open University
- ; The University of Edinburgh
- ; The University of Manchester
- ; UWE, Bristol
- ; University of Glasgow
- ; University of Plymouth
- ; University of Warwick
- AIT Austrian Institute of Technology
- AIT Austrian Institute of Technology GmbH
- AMOLF
- Aalborg University
- Academic Europe
- Baylor College of Medicine
- CNRS
- CNRS - Institut Fresnel
- CNRS CBMN UMR 5248
- Camden Cancer Research Center
- Campus Bio-Medico University
- Champalimaud Foundation
- Charles University in Prague, Faculty of Science
- DAAD
- Delft University of Technology
- Deutsches Krebsforschungszentrum
- ETH Zürich
- Emory University
- Erasmus MC (University Medical Center Rotterdam)
- ErasmusMC
- FUNDACION DE INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
- Georgetown University
- German Cancer Research Center (DKFZ) Heidelberg •
- GlycoDisplay ApS
- HBIGS Heidelberg Biosciences International Graduate School
- Harvard University
- 90 more »
- « less
-
Field
-
drug discovery. The project will bridge two key stages in drug discovery to identify targets and ligands synergistically in unmet cancer therapeutic needs. Project Objectives DNA encoded libraries have
-
Primary supervisor - Dr Stephanie Schüller Colorectal cancer (CRC) is the third most common and second most fatal cancer globally. Most cases of CRC are not hereditary but influenced by lifestyle
-
Primary supervisor - Prof Daniel Brewer Background With an incidence of >1.4 million cases worldwide, prostate cancer is the most common non-skin cancer in men. One in eight men will obtain a
-
clinical potential of altered lipid metabolism in prostate cancer (PCa). Through its modular and bidirectional nature with multiple entry points, this pipeline is expected to generate outputs at multiple
-
try again. 25th April 2024 Languages English English English PhD Candidate in membrane dynamics and cancer cell invasion Apply for this job See advertisement Job description A 3-year position in a
-
to develop novel inhibitors for the treatment of advanced prostate cancer, one of the leading causes of male cancer deaths. Advanced prostate cancer that has metastasised to the bones and other tissues is very
-
Polymerase II Gene Transcription in Cancer for a fixed-term employment for 3 years starting in August 2024. The mission of the lab is to unravel fundamental mechanisms that control the elongation phase
-
at the Faculty of Health, the multidisciplinary Cancer Research community ( RC Cancer) on the Kuopio campus. The position will be filled for a fixed term with a starting date between 1 August 2024 to 1 January
-
bone cancer largely affecting children. Treatment is often radical and debilitating, and despite the clinical urgency for newer more effective therapies, there has been no change in treatment options
-
Job related to staff position within a Research Infrastructure? No Offer Description Uterine cancer is the most common gynecological cancer in the Western world, with over 100,000 new patients annually